title: Barbiturate, analgesic, and caffeine withdrawal.
authors.forename: M
authors.initials: M
authors.lastname: Gallerani
authors.forename: C
authors.initials: C
authors.lastname: Zanotti
authors.forename: L
authors.initials: L
authors.lastname: Menozzi
authors.forename: A
authors.initials: A
authors.lastname: Montezemolo
authors.forename: V C
authors.initials: VC
authors.lastname: Monetti
authors.forename: M R
authors.initials: MR
authors.lastname: Tola
mesh_terms: D000328:Adult; D000632:Aminopyrine / Q000009:adverse effects*; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects; D001463:Barbiturates / Q000009:adverse effects*; D002110:Caffeine / Q000009:adverse effects*; D003128:Coma / Q000139:chemically induced; D004338:Drug Combinations; D005260:Female; D006212:Hallucinations / Q000139:chemically induced; D006801:Humans; D013375:Substance Withdrawal Syndrome
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D001463:Barbiturates; D004338:Drug Combinations; D000632:Aminopyrine; D002110:Caffeine; C020440:optalidon